## **Core Concept**
Long QT syndrome is a condition characterized by a prolongation of the QT interval on the electrocardiogram, which can predispose to a specific type of abnormal heart rhythm known as Torsades de Pointes. This condition can be congenital or acquired, with the latter often being drug-induced. Certain antiarrhythmic drugs are known to prolong the QT interval.

## **Why the Correct Answer is Right**
The correct answer, , is associated with the development of Long QT syndrome because it belongs to the class III antiarrhythmic drugs. Class III antiarrhythmic drugs work by blocking potassium channels, which leads to a prolongation of the action potential and refractory period, thereby prolonging the QT interval. This class of drugs includes agents like amiodarone, sotalol, and ibutilide. Among these, sotalol is particularly known for its risk of inducing Long QT syndrome and Torsades de Pointes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because it does not belong to a class of drugs commonly associated with QT prolongation.
- **Option B:** is incorrect as it represents a different pharmacological action not typically associated with the development of Long QT syndrome.
- **Option D:** is incorrect because, similar to Option A, it does not represent a drug class commonly linked with QT interval prolongation.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that when prescribing antiarrhythmic drugs, it's crucial to monitor the electrocardiogram for signs of QT prolongation, especially with drugs known to affect the QT interval. Sotalol, in particular, requires careful monitoring due to its risk of inducing Long QT syndrome and Torsades de Pointes.

## **Correct Answer:** . Sotalol